Comprehensive Connected Cancer Care (C4): Intervention Evaluation
Launched by TIMOTHY MULLETT · Mar 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Comprehensive Connected Cancer Care (C4) trial is studying a new program designed to help people with cancer navigate their care more effectively. This program focuses on improving communication between patients and healthcare providers and ensuring that patients receive the support they need from community services. It includes training for healthcare teams and offers educational resources that are sensitive to different cultures, helping patients feel more engaged and understood throughout their treatment journey.
To join the trial, participants should be adults aged 65 to 74 who have recently been diagnosed with cancer and have not yet started any treatment, like surgery or radiation. They should also have certain social needs that could affect their healthcare, such as financial concerns or access to resources. Participants can expect to receive personalized support and guidance during their cancer care while helping researchers understand the best ways to improve cancer treatment experiences for everyone. It's important to note that this trial requires participants to be comfortable using the internet, as it plays a key role in the program.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with newly diagnosed or recurrent cancer who have not initiated treatment of any kind, including surgery, medical management, and/or radiation
- • Patients with one reported social determinants of health (SDOH) need OR patients at high-risk for SDOH needs based on demographic information (racial \& ethnic minorities, medicaid/uninsured populations).
- • Willingness to provide informed consent to participate
- Exclusion Criteria:
- • Not able to understand and communicate in English
- • Unable and/or unwilling to access the internet on a phone, tablet, or computer
About Timothy Mullett
Timothy Mullett is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in clinical trial management and a focus on innovative therapeutic solutions, he leads initiatives that address unmet medical needs across various therapeutic areas. Mullett's collaborative approach fosters partnerships with healthcare professionals, regulatory bodies, and research institutions, ensuring rigorous adherence to ethical standards and regulatory compliance. His vision emphasizes the importance of data integrity and patient safety, driving the successful execution of clinical trials that contribute to the evolution of evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Patients applied
Trial Officials
Timothy Mullett, MD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported